The Manila Times

RespireRx Pharmaceuticals Inc. Announces SEC Order Making Findings and Revoking Registration of Securities and Future Plans with respect to its Common Stock

RespireRx Pharmaceuticals Inc. ('RespireRx”, 'RSPI”, 'Respondent” or the 'Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by ...
The Manila Times

Apyx Medical Corporation Announces Proposed Public Offering of Common Stock

Apyx Medical Corporation (Nasdaq: APYX) (the 'Company” or 'Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced ...

NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), today announced the closing of its previously announced securities purchase ...
The Nation UAE on MSN

FCC seeks report on availability of life-saving medicines

The Federal Constitutional Court on Monday directed the Drug Regulatory Authority of Pakistan (DRAP) to submit a comprehensive report on the nationwide availability of life-saving medicines and ...

Verrica Pharmaceuticals Inc.: Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results

Company reports $14.3 million in revenue in Q3'25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of license and collaboration revenue - - Reports positive feedback from the FDA ...
AllAfrica on MSN

NAFDAC Sensitises Officials On Drug Traceability, Paediatric Regulations to Curb Counterfeiting

The workshop focused on three major initiatives that form part of NAFDAC's broader strategy to protect consumers and strengthen the pharmaceutical supply chainThe National Agency for Food and Drug ...

Palatin Technologies, Inc.: Palatin Technologies Announces Closing of Upsized $18.2 Million Public Offering with the Full Exercise of the Underwriters' Over-Allotment Option

Trading of Palatin's common shares resumed trading on NYSE today, November 12, 2025, under the symbol "PTN" PRINCETON, N.J., Nov. 12, 2025 /PRNewswire/ -- Palatin ...
Agence France-Presse

Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy

Takeda (TSE:4502/NYSE:TAK) today announced new interim data from the Phase 1b, open-label, proof-of-concept study of subcutaneous mezagitamab (TAK-079), an anti-CD38 monoclonal antibody with ...

Captiva Spine announces FDA clearance for Flat-Panel C-Arm Calibrators and AI-Assisted Registration for WatchTower Spine Navigation, advancing future-ready access

Today's facilities demand enabling technologies that integrate seamlessly into existing workflows without driving up costs or requiring new infrastructure. The WatchTower Spine Navigation System was ...

Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer

This NDA submission is an important milestone, and it brings gedatolisib one step closer to becoming available for patients with HR+/HER2- advanced breast cancer,” said Brian Sullivan, CEO and ...

Veri Medtech (VRHI) Files Registration Statement for Proposed Initial Public Offering

Veriheal, a wholly-owned subsidiary of publicly-traded Veri Medtech Holdings - OTC Markets (“VRHI”), is a healthcare ...
The Caledonian-Record

Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the submission of ...